Monoclonal antibodies, against O1 serotype foot-and-mouth disease virus, from a natural bovine host, recognize similar antigenic features to those defined by the mouse.

References

1. Acharya R., Fry E., Stuart D., Fox G., Rowlands D., Brown F. 1989; The three-dimensional structure of foot-and-mouth disease virus at 2·9 Å resolution. Nature 337:709–716
   [Google Scholar]
2. Acharya R., Fry E., Logan D., Stuart D. I., Fox G., Rowlands D., Brown F. 1990; Structure offoot-and-mouth disease virus. In Use of χ- Ray Crystallography in the Design of Antiviral Agents pp 161–171 Laver W. G., Air G. M. Edited by San Diego: Academic Press;
   [Google Scholar]
3. Anderson D. V., Tucker E. M., Powell J. R., Porter P. 1987; Bovine monoclonal antibodies to F5(K99) pilus antigen of E. coli, produced by murine/bovine hybridomas. Veterinary Immunology and Immunopathology 15:233–237
   [Google Scholar]
4. Arnold E., Rossmann M. G. 1990; Analysis of the structure of a common cold virus, human rhinovirus 14, refined at a resolution of 3·0 Å. Journal of Molecular Biology 211:763–801
   [Google Scholar]
5. Barnett P. V., Pullen L., Staple R. F., Lee L. J., Butcher R., Parkinson D., Doel T. R. 1996; A protective anti-peptide antibody against the immunodominant site of A₂₄ Cruzeiro strain of foot-and- mouth disease virus and its reactivity with other subtype viruses containing the same minimum binding sequence. Journal of General Virology 77:1011–1018
   [Google Scholar]
6. Bittle J. L., Houghten R. A. others 1982; Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence. Nature 298:30–33
   [Google Scholar]
7. Brown F, Cartwright B. 1963; Purification of radioactive foot-and- mouth disease virus. Nature 199:1168–1170
   [Google Scholar]
8. Brown F. 1990; Picornaviruses. In Immunochemistry of Viruses II The Basis for Serodiagnosis and Vaccines pp 153–169 Van Regenmortel M. H. V., Neurath A. R. Edited by Amsterdam: Elsevier;
   [Google Scholar]
9. Carpenter W. C., Rai D. V., Samuel A. R., Höfner M. C. 1986; Comparison of a radioactive and non-radioactive method for sequencing foot-and-mouth disease virus isolates. Revue Scientifique et Technique Office International des Epizooties 15:875–882
   [Google Scholar]
10. Crowther J. R., Rowe C. A., Butcher R. 1993a; Characterization of monoclonal antibodies against a type SAT 2 foot-and-mouth disease virus. Epidemiology and Infection 111:391–406
    [Google Scholar]
11. Crowther J. R., Farias S., Carpenter W. C., Samuel A. R. 1993b; Identification of a fifth neutralizable site on type O foot-and-mouth disease virus following characterization of single and quintuple monoclonal antibody escape mutants. Journal of General Virology 74:1547–1553
    [Google Scholar]
12. Curry S., Fry E., Blakemore W., Abu-Ghazaleh R., Jackson T., King A., Lea S., Newman J., Stuart D. 1997; Dissecting the roles of VP0 cleavage and RNA packaging in picornavirus capsid stabilization: the structure of empty capsids of foot-and-mouth disease virus. Journal of Virology 71:9743–9752
    [Google Scholar]
13. DiMarchi R., Brooke G., Gale C., Cracknell V., Doel T., Mowat N. 1986; Protection of cattle against foot-and-mouth disease by a synthetic peptide. Science 232:639–641
    [Google Scholar]
14. Flynn J. N., Harkiss G. D., Hopkins J. 1989; Generation of a sheep x mouse heterohybridoma cell line (1C6.3a6T.1D7) and evaluation of its use in the production of ovine monoclonal antibodies. Journal of Immunological Methods 121:237–246
    [Google Scholar]
15. Garcia-Valcarcel M., Doel T., Collen T., Ryan M., Parkhouse M. E. 1996; Recognition of foot-and-mouth disease virus and its capsid protein VP1 by bovine peripheral T lymphocytes. Journal of General Virology 77:727–735
    [Google Scholar]
16. Garmendia A. E., Borca M. V., Morgan D. O., Baxt B. 1989; Analysis of foot-and-mouth disease virus-neutralizing idiotypes from immune bovine and swine with anti-murine idiotype antibody probes. Journal of Immunology 143:3015–3019
    [Google Scholar]
17. Groves D. J., Morris B. A., Clayton J. 1987; Preparation of a bovine monoclonal antibody to testosterone by interspecies fusion. Research in Veterinary Science 43:253–256
    [Google Scholar]
18. Groves D. J., Clayton J., Morris B. A. 1988; A bovine monoclonal antibody to oestrone/oestradiol prepared by a (murine × bovine) × bovine interspecies fusion. Veterinary Immunology and Immunopathology 18:95–101
    [Google Scholar]
19. Höfner M. C., Carpenter W. C., Donaldson A. I. 1993; Detection of foot-and-mouth disease virus RNA in clinical samples and cell culture isolates by amplification of the capsid coding region. Journal of Virological Methods 42:53–62
    [Google Scholar]
20. Icenogle J. P., Minor P. D., Ferguson M., Hogle J. M. 1986; Modulation of humoral response to a 12-amino-acid site on the poliovirus virion. Journal of Virology 68:3324–3333
    [Google Scholar]
21. Jackson T., Ellard F. M., AbuGhazaleh R., Brookes S. M., Blakemore W. E., Corteyn A. H., Stuart D. I., Newman J. W. I., King A. M. Q. 1996; Efficient infection of cells in culture by type O foot-and-mouth disease virus requires binding to cell surface heparan sulfate. Journal of Virology 70:5282–5287
    [Google Scholar]
22. Kitson J. D. A., McCahon D., Belsham G. J. 1990; Sequence analysis of monoclonal antibody resistant mutants of type O foot-and- mouth disease virus: evidence for the involvement of the three surface exposed capsid proteins in four antigenic sites. Virology 179:26–34
    [Google Scholar]
23. Lea S., Hernández J., Blakemore W., Brocchi E., Curry S., Domingo E., Fry E., Abu-Ghazaleh R., King A. M. Q., Newman J., Stuart D., Mateu M. G. 1994; The structure and antigenicity of a serotype C foot-and-mouth disease virus. Structure 2:123–139
    [Google Scholar]
24. Logan D., Abu-Ghazaleh R., Blakemore W., Curry S., Jackson T., King A., Lea S., Lewis R., Newman J., Parry N., Rowlands D., Stuart D., Fry E. 1993; Structure of a major immunogenic site of foot-and- mouth disease virus. Nature 362:566–568
    [Google Scholar]
25. McCullough K. C., Crowther J. R., Butcher R. N. 1985; Alteration in antibody reactivity with foot-and-mouth disease virus (FMDV) 146S antigen before and after binding to a solid phase or complexing with specific antibody. Journal of Immunological Methods 82:91–100
    [Google Scholar]
26. McCullough K. C., Parkinson D., Crowther J. R. 1988; Opsonisation-enhanced phagocytosis of foot-and-mouth disease virus. Immunology 65:187–192
    [Google Scholar]
27. McGuire T. C., Musuoke A. J., Kurtti T. 1979; Functional properties of bovine IgG₁ and IgG₂; interaction with complement, macrophages, neutrophils and skin. Immunology 38:249–256
    [Google Scholar]
28. Martínez M. A., Hernández J., Piccone M. E., Palma E. L., Domingo E., Mateu M. G. 1991; Two mechanisms of antigenic diversification of foot-and-mouth disease virus. Virology 184:695–706
    [Google Scholar]
29. Mateu M. G. 1995; Review. Antibody recognition of picornaviruses and escape from neutralization: a structural review. Virus Research 38:1–24
    [Google Scholar]
30. Mateu M. G., Martínez M. A., Capucci L., Andreu D., Giralt E., Sobrino F., Brocchi E., Domingo E. 1990; A single amino acid substitution affects multiple overlapping epitopes in the major antigenic site of foot-and-mouth disease virus of serotype C. Journal of General Virology 71:629–637
    [Google Scholar]
31. Mateu M. G., Camarero J. A., Andreu D., Giralt E., Domingo E. 1995a; Direct evaluation of the immunodominance of a major antigenic site of foot-and-mouth disease virus in a natural host. Virology 206:298–306
    [Google Scholar]
32. Mateu M. G., Andreu D., Domingo E. 1995b; Antibodies raised in a natural host and monoclonal antibodies recognize similar antigenic features of foot-and-mouth disease virus. Virology 210:120–127
    [Google Scholar]
33. Mulcahy G., Gale C., Robertson P., Iyisan S., DiMarchi R. D., Doel T. R. 1990; Isotype responses of infected virus-vaccinated and peptide- vaccinated cattle to foot-and-mouth disease virus. Vaccine 8:249–256
    [Google Scholar]
34. Murray V. 1989; Improved double stranded DNA sequencing using the linear polymerase chain reaction. Nucleic Acids Research 17:8889
    [Google Scholar]
35. Novotny J., Handschumacher M., Haber E., Bruccoleri R. E., Carlson W. B., Fanning D. W., Smith J. A., Rose G. D. 1986; Antigenic determinants in proteins coincide with surface regions accessible to large probes (antibody domains). Proceedings of the National Academy of Sciences, USA 83:226–230
    [Google Scholar]
36. Ostberg L., Pursch E. 1983; Human × (mouse × human) hybridomas stably producing human antibodies. Hybridoma 2:361–367
    [Google Scholar]
37. Pfaff E., Mussgay M., Bohm H. O., Schulz G. E., Schaller H. 1982; Antibodies against a preselected peptide recognize and neutralize foot-and-mouth disease virus. EMBO Journal 1:869–874
    [Google Scholar]
38. Ping L.-H., Lemon S. M. 1992; Antigenic structure of human hepatitis A virus defined by analysis of escape mutants selected against murine monoclonal antibodies. Journal of Virology 66:2208–2216
    [Google Scholar]
39. Plumas-Marty B., Taibi A., Pessoa H., Verwaerde C., Loyens M., Pommier V., Velge P., Capron A., Ouaissi A. 1993; Trypanosoma cruzi glutathione-binding proteins (TcGBP): protection induced by native proteins in an experimental model and analysis of the antibody response. Research in Immunology 144:553–563
    [Google Scholar]
40. Samuel A. R., Knowles N. J., Samuel G. D., Crowther J. R. 1991; Evaluation of a trapping ELISA for the differentiation of foot-and-mouth disease virus using monoclonal antibodies. Biologicals 19:299–310
    [Google Scholar]
41. Sayle R. A., Milner-White E. J. 1995; RASMOL: biomolecular graphics for all. Trends in Biochemical Sciences 20:374–376
    [Google Scholar]
42. Sellei J. 1984; Interaction of bovine immunoglobulins with complement. Comparative Immunology, Microbiology and Infectious Diseases 10:93–98
    [Google Scholar]
43. Smith T. J., Chase E. S., Schmidt T. J., Olson N. H., Baker T. S. 1996; Neutralizing antibody to human rhinovirus 14 penetrates the receptor-binding canyon. Nature 383:350–354
    [Google Scholar]
44. Spira G., Paizi M., Mazar S., Nussbaum G., Mukherjee S., Casadevall A. 1996; Generation of biologically active anti-Crypto-coccus neoformans IgG, IgE and IgA isotype switch variants antibodies by acridine orange mutagenesis. Clinical and Experimental Immunology 105:436–442
    [Google Scholar]
45. Strohmaier K., Franze R., Adam K. H. 1982; Location and characterization of the antigenic portion of the FMDV immunizing protein. Journal of General Virology 59:295–306
    [Google Scholar]
46. Thomas A. A. M., Woortmeijer R. J., Barteling S. J., Meloen R. H. 1988; Evidence for more than one important neutralizing site on foot- and-mouth disease virus. Archives of Virology 99:237–242
    [Google Scholar]
47. Tucker E. M., Dain A. R., Clarke S. W., Donker R. A. 1984; Specific bovine monoclonal antibody produced by a re-fused mouse/calf hybridoma. Hybridoma 3:171–176
    [Google Scholar]
48. Xie Q.-C., McCahon D., Crowther J. R., Belsham G. J., McCullough K. C. 1987; Neutralization of foot-and-mouth disease virus can be mediated through any of at least three separate antigenic sites. Journal of General Virology 68:1637–1647
    [Google Scholar]
49. Xu Y., Oomen R., Klein M. H. 1994; Residue at position 331 in the IgG₁ and IgG₄ C-H2 domains contributes to their differential ability to bind and activate complement. Journal of Biological Chemistry 269:3469–3474
    [Google Scholar]